Piramal Pharma to invest USD 90M in expansion of two US sites
Mumbai: Piramal Pharma Limited, a global pharmaceuticals and wellness company, in conjunction with the 2025 Select USA Investment Summit, has committed to a $90M investment plan towards expanding two of the Company’s US facilities.
These expansions are in response to ongoing demand from US customers, in support of the trend towards US onshoring of drug supply. Piramal Pharma is making brownfield expansions to existing sites, financed by bank loans and internal accruals, which is the fastest, lowest risk, and most economical way to add new capacities to the US market.
Piramal Pharma’s Lexington, Kentucky, facility specializes in sterile compounding, liquid filling, and lyophilization for sterile injectable drug products. The site’s expansion—which includes 24,000 square feet of manufacturing space and a new laboratory—adds commercial-scale manufacturing. Key additions include a new filling line, two commercial-size lyophilizers, a special capping machine, and an external vial washer. The facility is expected to be completed and online by late 2027.
Piramal Pharma’s Riverview, Michigan site, develops and manufactures active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs). Here, the company is adding a commercial-scale suite specifically for the development and manufacturing of payload-linkers. These high potency APIs are used in the development of antibody-drug conjugates (ADCs) and other bioconjugate drugs. The new payloadlinker suite is expected to be operational before the end of 2025. These site expansions are expected to generate greater opportunities for integrated ADC projects. Working synergistically, they will play a vital role in Piramal Pharma’s integrated ADC development and manufacturing program, branded ADCelerate. With development and commercial-scale capabilities in mABs, payload-linkers, conjugations, and fill/finish, ADCelerate speeds timelines, enabling project initiation to GMP drug product in just 12 months with uncompromised quality.
